Xi'an LiSun Biological Technology Co. Ltd.
                                                                                                           
Member Supplier
Years
Since
Menu

High purity Orlistat for weight loss

Price Negotiable
Price: Negotiable
MOQ: 1kg
Delivery Time: 3-5 Work days
Brand: LiSun Biological
Product Description

High purity Orlistat for weight loss

Orlistat is a drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet.
Orlistat is the saturated derivative of lipstatin, a potent natural inhibitor of pancreatic lipases isolated from the bacterium Streptomyces toxytricini. However, due to its relative simplicity and stability, orlistat was chosen over lipstatin for development as an anti-obesity drug.

Detailed Images

High purity Orlistat for weight loss

English Name: Orlistat
CAS : 96829-58-2
Purity:99%
Appearance:White powder
White crystalline powder
Molecular Weight:495.73482
Density:0.976 g/cm3
Boiling Point:615.9 oC at 760 mmHg
Melting Point:<50oC
Flash Point:326.3 oC
Storage Temperature:2-8°C
Refractive index:1.469
Solubility:DMSO: 19 mg/mL in water

Function

Orlistat /Tetrahydrolipstatin is used with a low-calorie diet to help you lose weight and to maintain your weight after weight loss.
Orlistat /Tetrahydrolipstatin is in a class of drugs called lipase inhibitors. It works in your intestines, where it blocks some of the fat you eat from being absorbed and digested. This undigested fat is then removed in your bowel movements .

Applications:
Orlistat /Tetrahydrolipstatin is used for the treatment of obesity.The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% and 24.8% achieved at least a 10% decrease in body mass.After orlistat was stopped, a significant number of subjects regained weight—up to 35% of the weight they had lost.
The incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%).Long-term use of orlistat also leads to a modest reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood pressure respectivel


Get in Touch

Have questions about our products or want to discuss a custom order? Our team is ready to help you.

Company Xi'an LiSun Biological Technology Co. Ltd.
Location Building qinjin Beilin District Xi'an Road,1-601
Contact Person kaiyu

Request A Quote

Please check your email address.
Your message must be at least 20 characters.